Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1999
11/17/1999EP0604566B1 Chimeric and/or growth-restricted flaviviruses
11/17/1999CN1235639A Reconstituted human anti-HM1.24 antibody
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235556A Materials and methods relating to diagnosis and treatment of pre-eclampsia and diabetes
11/17/1999CN1235555A Compounds and methods for treatment and diagnosis of mycobacterial infections
11/17/1999CN1235513A Nucleic acid and amino acid sequences ralating to helicobacter pylori and vaccine compositions thereof
11/17/1999CN1235164A Peptide for vaccine of schistosomiasis
11/17/1999CN1235163A Peptide for vaccine of schistosomiasis
11/17/1999CN1235053A Oral cholera vaccine
11/16/1999US5986170 Murine model for human carcinoma
11/16/1999US5986069 Human haemopoietic maturation factor polypeptides
11/16/1999US5986065 Antibodies for inhibiting blood coagulation and methods of use thereof
11/16/1999US5986064 Antibodies which specifically bind to human tumor-associated Kazal inhibitor-like polypeptide
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986055 CDK2 interactions
11/16/1999US5986051 Genes of Helicobacter pylori necessary for the regulation and maturation of urease and their use
11/16/1999US5985832 Inhibiting osteoclastogenesis by administering osteoclast inhibitor protein (oip) to a cell
11/16/1999US5985828 Screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies
11/16/1999US5985654 Gene which expresses a protein corresponding to the conserved exposed region of the m6 protein, a virulence factor of streptococcus; poxvirus such as vaccinia containing m6 gene used as vaccines against streptococcal infection
11/16/1999US5985641 Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies
11/16/1999US5985640 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
11/16/1999US5985631 Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
11/16/1999US5985619 Amplification of target nucleic acid
11/16/1999US5985610 Gene expression in host cell of conformational epitopes
11/16/1999US5985609 Process for preparing hepatitis C virus envelope glycoproteins
11/16/1999US5985604 Polynucleotide
11/16/1999US5985603 P2x receptor DNA and protein sequence
11/16/1999US5985600 Nucleic acid encoding delta opioid receptor
11/16/1999US5985585 Competitive binding; detection
11/16/1999US5985583 Hybridization; measurement signal transduction
11/16/1999US5985580 Antibodies which specifically bind to the thymokine lymphotactin
11/16/1999US5985552 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
11/16/1999US5985546 Forming culture product; cytopathic effect
11/16/1999US5985541 Purified polypeptide; quantitative analysis
11/16/1999US5985336 Nutrient formulation and process for feeding young poultry and other animals
11/16/1999US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999US5985320 Drug delivery; medical diagnosis; genetic engineering; administering agent that interacts with cell surface receptors
11/16/1999US5985318 Influenza virus vaccines; immunogens; side effect reduction; nose drops
11/16/1999US5985290 Purified pancreatic tumor cell lines and related compositions and method
11/16/1999US5985289 Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
11/16/1999US5985288 Outer membrane protein P1 and peptides of Haemophilus influenzae type B
11/16/1999US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections
11/16/1999US5985286 Adenyl cyclase-hemolysin (ac-hly) protein,
11/16/1999US5985285 Vaccines for plague
11/16/1999US5985284 To protect against mucosal infection with shigella.
11/16/1999US5985281 Antibody directed enzyme prodrug therapy (adept) using a non-naturally occuring mutant form of a host enzyme, especially a mutant form of ribonuclease.
11/16/1999US5985280 Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985278 Anti-αV-integrin monoclonal antibody
11/16/1999US5985277 Useful for diagnosis and treatement of corynebacterium infections and diseases.
11/16/1999US5985270 Antitumor
11/16/1999US5985264 IL-12 Stimulation of Neonatal immunity
11/16/1999US5985262 Method of treatment with epithelium derived T-cell factor
11/16/1999CA2088600C Herpes simplex virus vp16 vaccines
11/16/1999CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates
11/13/1999CA2248987A1 Novel compounds
11/11/1999WO1999057304A1 Bacteriophage assay
11/11/1999WO1999057303A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
11/11/1999WO1999057289A2 INHIBIN-HBc FUSION PROTEIN
11/11/1999WO1999057284A2 Attenuated influenza viruses
11/11/1999WO1999057283A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/11/1999WO1999057280A2 Neisseria meningitidis antigens and compositions
11/11/1999WO1999057278A2 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI)
11/11/1999WO1999057277A2 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
11/11/1999WO1999057275A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate
11/11/1999WO1999057271A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999WO1999057270A2 Human receptor molecules
11/11/1999WO1999057267A2 Human epididymal glytathione peroxidase
11/11/1999WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999WO1999057241A2 Myelin basic protein peptides and uses thereof
11/11/1999WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999WO1999057152A1 Oral administration of immunoglobulins for treating autoimmune hearing loss
11/11/1999WO1999057151A2 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
11/11/1999WO1999057150A2 Multivalent antibody constructs
11/11/1999WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999WO1999057142A2 Vaccine for $i(pseudomonas aeruginosa)
11/11/1999WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor
11/11/1999WO1999056778A1 The cytokine family member, 2-19
11/11/1999WO1999056776A2 Adjuvant composition and methods for its use
11/11/1999WO1999056775A1 Use of interleukin-18 as vaccine adjuvant
11/11/1999WO1999056774A1 Viral chimeras comprised of caev and hiv-1 genetic elements
11/11/1999WO1999056773A2 Composition comprising tumor cells and extracts and method of using thereof
11/11/1999WO1999056772A2 Hepatitis vaccine
11/11/1999WO1999056771A2 Methods of raising animals for meat production
11/11/1999WO1999056768A1 Methods for treating diabetes by inhibiting gdf-8
11/11/1999WO1999056763A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999WO1999056755A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
11/11/1999WO1999056700A2 Avian polyomavirus vaccines in psittacine birds
11/11/1999WO1999049316A3 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
11/11/1999WO1999048525A8 Hib/dtpa vaccine composition and methods of preparation
11/11/1999WO1999048348A8 Helicobacter pylori derived factor which inhibits ena-78 secretion
11/11/1999WO1999045031A9 Cd147 binding molecules as therapeutics
11/11/1999WO1999041402A3 Targeting of genetic vaccine vectors
11/11/1999WO1999037778A3 Compositions and methods for detecting and treating prostate cancer
11/11/1999WO1999029863A9 Human interferon-epsilon: a type i interferon
11/11/1999WO1999027105A3 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/11/1999DE19819846A1 Multivalente Antikörper-Konstrukte Multivalent antibody constructs
11/11/1999DE19805815C1 Diagnostikum zum Erkennen der autoimmunen Hepatitis Diagnostic tool for the detection of autoimmune hepatitis
11/11/1999CA2753381A1 Protein purification by ion exchange chromatography
1 ... 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 ... 1823